Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476047
Status:
COMPLETED
Last Update Posted:
2017-10-12
First Post:
2007-05-17
Brief Title:
Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Organization Data
Organization:
Fred Hutchinson Cancer Center
Class:
OTHER
Study ID:
PSOC 2301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Mazyar Shadman
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fred Hutchinson Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |